Article
Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Frontiers in immunology - 1 Jan 2021
Yan Zongcai, He Meiling, He Lifeng, Wei Liuxia, Zhang Yumei
Abstract excerpt
Background: Hepatocellular carcinoma (HCC) is a highly lethal disease. Effective prognostic tools to guide clinical decision-making for HCC patients are lacking. Objective: We aimed to establish a robust prognostic model based on differentially expressed genes (DEGs) in HCC. Methods: Using datasets from The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and the International Genome Consortium...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
